Free Trial

Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Rating of "Moderate Buy" from Analysts

Tempus AI logo with Medical background

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) has earned an average recommendation of "Moderate Buy" from the ten ratings firms that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $50.89.

Several brokerages recently commented on TEM. Stifel Nicolaus downgraded Tempus AI from a "buy" rating to a "hold" rating and raised their price objective for the stock from $45.00 to $65.00 in a research note on Monday. Needham & Company LLC reissued a "buy" rating and set a $47.00 target price on shares of Tempus AI in a research note on Wednesday, August 7th. Loop Capital lifted their price target on shares of Tempus AI from $48.00 to $57.00 and gave the company a "buy" rating in a research note on Tuesday, October 15th. Bank of America lowered shares of Tempus AI from a "buy" rating to a "neutral" rating and raised their price objective for the stock from $45.00 to $60.00 in a report on Wednesday, October 2nd. Finally, Piper Sandler began coverage on shares of Tempus AI in a research note on Monday, August 12th. They issued a "neutral" rating and a $40.00 target price for the company.

View Our Latest Stock Report on TEM

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently made changes to their positions in TEM. First Horizon Advisors Inc. bought a new position in Tempus AI in the third quarter valued at about $30,000. Sandia Investment Management LP acquired a new position in shares of Tempus AI during the 2nd quarter valued at $136,000. Vestor Capital LLC acquired a new stake in Tempus AI in the third quarter worth $153,000. IQ EQ FUND MANAGEMENT IRELAND Ltd bought a new stake in Tempus AI in the third quarter valued at $258,000. Finally, Clarus Group Inc. acquired a new position in shares of Tempus AI during the third quarter valued at about $283,000.

Tempus AI Trading Down 6.7 %

Shares of TEM stock traded down $4.97 on Monday, reaching $68.80. 1,035,606 shares of the stock were exchanged, compared to its average volume of 1,172,233. The firm's 50 day moving average price is $50.22. The company has a quick ratio of 3.52, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI has a one year low of $22.89 and a one year high of $77.00.

Tempus AI Company Profile

(Get Free Report

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

See Also

Analyst Recommendations for Tempus AI (NASDAQ:TEM)

Should you invest $1,000 in Tempus AI right now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines